Royce & Associates LP purchased a new stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 19,559 shares of the company’s stock, valued at approximately $769,000.
A number of other institutional investors and hedge funds have also modified their holdings of the business. Eagle Bay Advisors LLC grew its stake in Nu Skin Enterprises by 37.1% in the second quarter. Eagle Bay Advisors LLC now owns 809 shares of the company’s stock valued at $35,000 after purchasing an additional 219 shares in the last quarter. Royal Bank of Canada grew its stake in Nu Skin Enterprises by 118.2% in the third quarter. Royal Bank of Canada now owns 1,150 shares of the company’s stock valued at $38,000 after purchasing an additional 623 shares in the last quarter. Robeco Institutional Asset Management B.V. purchased a new position in Nu Skin Enterprises in the first quarter valued at about $51,000. Quadrant Capital Group LLC grew its stake in Nu Skin Enterprises by 135.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,646 shares of the company’s stock valued at $69,000 after purchasing an additional 948 shares in the last quarter. Finally, Counterpoint Mutual Funds LLC purchased a new position in Nu Skin Enterprises in the first quarter valued at about $103,000. Hedge funds and other institutional investors own 89.06% of the company’s stock.
Insider Buying and Selling at Nu Skin Enterprises
In other Nu Skin Enterprises news, Director Andrew D. Lipman sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $28.99, for a total value of $57,980.00. Following the completion of the transaction, the director now owns 58,625 shares of the company’s stock, valued at approximately $1,699,538.75. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, Director Edwina D. Woodbury sold 1,255 shares of the stock in a transaction that occurred on Tuesday, May 9th. The stock was sold at an average price of $37.87, for a total value of $47,526.85. Following the completion of the transaction, the director now directly owns 15,469 shares of the company’s stock, valued at approximately $585,811.03. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Andrew D. Lipman sold 2,000 shares of the stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $28.99, for a total value of $57,980.00. Following the completion of the transaction, the director now directly owns 58,625 shares of the company’s stock, valued at $1,699,538.75. The disclosure for this sale can be found here. Insiders sold a total of 7,255 shares of company stock valued at $238,307 in the last quarter. Corporate insiders own 2.00% of the company’s stock.
Nu Skin Enterprises Price Performance
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last posted its quarterly earnings results on Tuesday, August 1st. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.53 by $0.01. The firm had revenue of $500.26 million during the quarter, compared to analysts’ expectations of $512.35 million. Nu Skin Enterprises had a return on equity of 12.88% and a net margin of 3.43%. Research analysts anticipate that Nu Skin Enterprises, Inc. will post 2.42 EPS for the current year.
Nu Skin Enterprises Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 6th. Shareholders of record on Friday, August 25th will be issued a $0.39 dividend. The ex-dividend date is Thursday, August 24th. This represents a $1.56 annualized dividend and a yield of 5.95%. Nu Skin Enterprises’s dividend payout ratio (DPR) is 110.64%.
Analysts Set New Price Targets
Several analysts have recently issued reports on the company. DA Davidson decreased their price target on Nu Skin Enterprises from $38.00 to $29.00 and set a “neutral” rating for the company in a research note on Thursday. Stifel Nicolaus decreased their price target on Nu Skin Enterprises from $43.00 to $35.00 and set a “hold” rating for the company in a research note on Wednesday. Finally, StockNews.com began coverage on Nu Skin Enterprises in a research note on Thursday, May 18th. They set a “hold” rating for the company. Five analysts have rated the stock with a hold rating, According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $36.00.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc, together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products.
Featured Articles
- Five stocks we like better than Nu Skin Enterprises
- How to Calculate Stock Profit
- MarketBeat Week in Review – 07/31 – 08/04
- Stocks in the Dow: About the Dow Jones Industrial Average (DJIA)
- 3 Best Meme ETFs to Buy Now
- How to Invest in Small Cap Stocks
- XPO Keeps Reaching New Highs: Markets Love the Stock
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.
